The purpose of the study is to further understand the closed-loop feature in chronically implanted patients by characterizing the efficacy of the next generation, spinal cord stimulator.

Inclusion Criteria:

• 18 years of age or older

• Candidate is undergoing Medtronic SCS device trial for chronic, intractable pain of the trunk and/or limbs

• If being treated for low-back and/or leg pain,

  • the baseline overall^ Visual Analog Scale is ≥ 60 mm and
  • baseline back and/or leg pain Visual Analog Scale is ≥60 mm. ^Average overall pain in the back and/or leg in the 72 hours prior to the baseline visit, measured using Visual Analog Scale.

• If being treated for upper limb pain - baseline Visual Analog Scale is ≥ 60 mm for upper limb pain

• On stable (no change in dose, route, or frequency) prescribed pain medications being used for back and leg pain or upper limb pain, as determined by the investigator, for at least 28 days prior to device trial

• Willing and able to provide signed and dated informed consent

• Willing and able to comply with all study procedures and visits

Exclusion Criteria:

• Indicated for an SCS device to treat stable intractable Angina Pectoris or Peripheral Vascular Disease of Fontaine Stage III or higher
• Previously trialed or implanted with spinal cord stimulator, peripheral or vagus nerve stimulator, deep brain stimulator or an implantable intrathecal drug delivery system
• Currently participating, or plans to participate, in another investigational study unless written approval is provided by the Medtronic study team
• Major psychiatric comorbidity or other progressive diseases that may confound study results, as determined by the Investigator
• Serious drug-related behavioral issues (e.g. alcohol dependency, illegal substance abuse), as determined by the Investigator
• Pregnant or planning on becoming pregnant (if female and sexually active, subject must be using a reliable form of birth control, be surgically sterile, or be at least 2 years post-menopausal)
• Be involved in an injury claim or under current litigation

All subjects implanted with a Spinal Cord Stimulator.

From Implant through 3 months post activation

All device/therapy-related adverse events (AEs) related to the implanted spinal cord stimulation (SCS) system, accessories, surgical procedures, and therapy were collected. Non-serious, non-device/therapy-related AEs were not collected. All serious AEs were collected regardless of device/therapy-relatedness. AEs were not collected separately by whether the closed loop feature was On or Off; it was pre-specified to report the AE rates through the 3-month visit for all implanted subjects.